Tatsuo Ohira

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +15

Photodynamic Therapy (PDT) for Lung Cancers

Jitsuo Usuda, Harubumi Kato, Tetsuya Okunaka et al. · Journal of Thoracic Oncology · 2006 · 250 citations

Medicine, Cancer Biology, Oncology +10

WNT7a induces E-cadherin in lung cancer cells

Tatsuo Ohira, Robert M. Gemmill, Kevin L. Ferguson et al. · Proceedings of the National Academy of Sciences · 2003 · 180 citations · Full text

Life Sciences, Cell Biology, Oncology +17

High-quality 3-dimensional image simulation for pulmonary lobectomy and segmentectomy: results of preoperative assessment of pulmonary vessels and short-term surgical outcomes in consecutive patients undergoing video-assisted thoracic surgery†

Masaru Hagiwara, Yoshihisa Shimada, Yasufumi Kato et al. · European Journal of Cardio-Thoracic Surgery · 2014 · 119 citations · Full text

Medicine, Radiology, Surgery +16

Novel Epidermal Growth Factor Receptor Mutation-Specific Antibodies for Non-small Cell Lung Cancer: Immunohistochemistry as a Possible Screening Method for Epidermal Growth Factor Receptor Mutations

Yasufumi Kato, Nir Peled, Murry W. Wynes et al. · Journal of Thoracic Oncology · 2010 · 118 citations · Full text

Medicine, Oncology, Pathology +9